DERM
Journey Medical CorpNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$171.94M
P/E Ratio
—
EPS
$-0.47
Beta
1.04
52W High
$9.55
52W Low
$4.31
50-Day MA
$7.27
200-Day MA
$7.51
Dividend Yield
—
Profit Margin
-18.50%
Forward P/E
172.41
PEG Ratio
—
About Journey Medical Corp
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
Fundamentals
| Revenue (TTM) | $61.86M |
| Gross Profit (TTM) | $40.93M |
| EBITDA | $-3.91M |
| Operating Margin | -2.76% |
| Return on Equity | -44.00% |
| Return on Assets | -5.84% |
| Revenue/Share (TTM) | $2.52 |
| Book Value | $1.17 |
| Price-to-Book | 4.44 |
| Price-to-Sales (TTM) | 2.78 |
| EV/Revenue | 2.305 |
| EV/EBITDA | 17.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 18.10% |
| Shares Outstanding | $21.33M |
| Float | $14.84M |
| % Insiders | 31.10% |
| % Institutions | 56.24% |
Historical Volatility
HV 10-Day
66.16%
HV 20-Day
140.79%
HV 30-Day
117.96%
HV 60-Day
92.19%
HV Rank
98.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($13.25 target)
3
BuyData last updated: 4/14/2026